Abstract. An eighty-year-old man who had complained of skin pigmentation and weight loss was referred to our hospital. Upon physical examination, marked hyperpigmentation was found on the whole body including oral mucosa, tongue and fingernails. Endocrinological findings showed increased ACTH (126 pg/ml) and normal serum cortisol (15.4 µg/dl). First, we used a 250 µg cosyntropin stimulation test which is valid to diagnose Addison's disease, resulting in an adequate cortisol response. Second, we performed 1 µg cosyntropin stimulation test, and the cortisol response was blunted. Since the diagnosis of Addison's disease was fairly certain, he was treated with hydrocortisone 15 mg/day, and improvement of his skin pigmentation and an increase in body weight were observed. To our knowledge, this is the first report that 1 µg cosyntropin stimulation test was helpful to make diagnosis as having Addison's disease rather than the 250 µg cosyntropin stimulation test, although it is established that the 1 µg cosyntropin stimulation test is useful in secondary or relative adrenal insufficiency.
ADDISON'S disease might cause persistent nausea, fatigue, hypoglycemia, weight loss, hyponatremic dehydration, hyperkalemia, and darkening of the skin [1, 2] . When the disease remains undiagnosed or untreated, there is the possibility of it leading to unnecessary morbidity and mortality. However, it is sometimes difficult to recognize and make the diagnosis of primary adrenal insufficiency, because there are no flawless diagnostic procedures.
Low dose (1 µg) and standard dose (250 µg) cosyntropin stimulation test are reported as assessment procedures of adrenal function [3] [4] [5] . It is suggested that the standard cosyntropin stimulation test, as well as urine findings and physical examinations, is crucial to make an accurate diagnosis of Addison's disease [3] , while several cases with primary adrenal insufficiency had an adequate response to 250 µg cosyntropin [6, 7] . The validity of low dose cosyntropin stimulation test is reported only in making diagnosis of secondary or relative adrenal insufficiency [4, 5, 8, 9] , but not primary adrenal insufficiency.
We should consider alternative procedures useful to diagnose primary adrenal insufficiency. Here, we report a patient who was diagnosed as having Addison's disease confirmed by low dose cosyntropin stimulation test.
Case Report
An eighty-year-old man who had complained of skin pigmentation and weight loss was referred to our hospital. One year before this admission, his skin darkened gradually and a weight reduction of 18 kg in a year was evident. Past medical history included pha-ryngeal carcinoma at the age of 78, for which the tumor had been surgically removed. There was no history of tuberculosis. No endocrine disease had been noticed in his family. He did not have a history of alcohol consumption or smoking. Upon physical examination, his height was 157.1 cm and weight was 48.0 kg. His pulse was 68 beats per minute and blood pressure was 118/62 mmHg. Marked hyperpigmentation was found on the whole body including the oral mucosa, tongue and fingernails (Fig. 1 ). There were no findings on his chest and abdomen. Neurologic examination revealed no abnormalities.
Laboratory findings on admission are summarized in Table 1 and showed no abnormalities except for anemia or electrolyte disturbances including hyponatremia and hypochloridemia. Table 2 lists the results of the endocrinological findings and revealed elevation of ACTH, although basal level of serum cortisol was within the normal range. Urine 17-hydroxycorticosteroid and 17-ketosteroid levels were suppressed. Basal levels of plasma renin activity and plasma aldosterone concentration were within the normal range. Additionally, antibodies to adrenal cortex and human immunodeficiency virus were seronegative. CT scan imaging of the bilateral adrenal glands and magnetic resonance imaging of the pituitary gland showed no abnormalities.
Based upon the physical examinations and the endocrinological findings, a diagnosis of Addison's disease was suspected. First, we performed a 250 µg cosyn- Fig. 2A) . Second, a 1 µg cosyntropin stimulation test was performed, and the cortisol response was blunted (Fig. 2B) . Each cosyntropin infusion was given intravenously at 8 AM after an overnight fast. Serum cortisol levels were measured at baseline, 30 and 60 minutes after cosyntropin infusion.
With the results of the 1 µg cosyntropin stimulation test and the other clinical findings, the diagnosis of Addison's disease was fairly certain. Therefore, the patient was given a daily oral dose of 15 mg of hydrocortisone. After treatment of hydrocortisone, serum sodium levels were maintained in the normal range, and the skin pigmentation and the reduction of his body weight were improved gradually. The levels of plasma aldosterone concentration and plasma renin activity did not indicate the destruction of zona glomerulosa (Fig. 3) .
Discussion
In this patient, a low dose cosyntropin stimulation test was helpful to make the diagnosis of Addison's disease rather than the standard dose cosyntropin stimulation test. This indicates the possibility that the low dose cosyntropin stimulation test is useful in primary adrenal insufficiency as well as in secondary or relative adrenal failure.
Standard cosyntropin test is performed by administering 250 µg of cosyntropin intravenously and then measuring serum cortisol levels 30 and 60 minutes later [6, [10] [11] [12] . With a normal result for the test, the serum cortisol level after cosyntropin stimulation is greater than at least 18.0 µg/dl [6, 7, 10-13]. Our case had an adequate response of cortisol to 250 µg of cosyntropin. It was reported that all cases with primary adrenal insufficiency have an inadequate response of cortisol to the standard dose of ACTH [11, 12] , while May and Carey, and Soule have suggested that the sensitivity of the test is 95%, respectively [6, 7] . Therefore, it is likely that some cases with primary adrenal insufficiency have an inadequate response to 250 µg cosyntropin.
Cortisol response to a low dose or a standard dose ACTH is almost identical in normal subjects [4] . The low dose cosyntropin stimulation test is established to have higher sensitivity and specificity compared to the standard dose cosyntropin stimulation test in making the diagnosis of secondary or relative adrenal insufficiency [4, 5, 8, 9] . It is suggested that 250 µg cosyntropin is a powerful adrenal stimulus at supraphysiological, but not physiological doses [14] . It is speculated that some adrenocortical cells remain intact and are able to secrete cortisol in secondary adrenal insufficiency. Similarly, most of the cellular function is preserved in critically ill patients with relative adrenal insufficiency. In our case, the function of zona glomer- ulosa was considered intact based on the results of plasma aldosterone concentration and plasma renin activity, while primary hypoadrenalism invariably accompanies mineralocorticoid deficiency [15] . Taken together, the cortisol response to cosyntropin is likely to depend on the degree of adrenal failure, and some of the adrenocortical cells in our case might be intact in spite of primary adrenal insufficiency. Subclinical adrenal insufficiency states are found in a longitudinal follow-up of cases with HIV disease, adrenal autoantibodies, or a family history of adrenoleukodystrophy or adrenomyeloneuropathy [10, [16] [17] [18] [19] . The general concept of subclinical adrenal insufficiency is that the patients with HIV disease or adrenal autoantibodies have no endocrine indicators. In these patients, standard dose cosyntropin test shows a normal cortisol response, and the low dose cosyntropin stimulation test is sometimes blunted [16] [17] [18] . However, our case was different from these patients because he had clinical findings of Addison's disease. Furthermore, based on the family history and serological findings, the characteristics of conditions such as HIV disease or adrenal autoantibodies, or a family history of adrenoleukodystrophy or adrenomyeloneuropathy, were not evident.
In this case, the adrenal status might be in the process of exacerbation. At least, the levels of plasma aldosterone concentrations and plasma renin activities did not indicate the deterioration of adrenal insufficiency. It is difficult to confirm it after glucocorticoid replacement therapy has been initiated, because the treatment affects the secretion of ACTH and cortisol. If we could have performed cosyntropin stimulation test repeatedly, the deterioration might be confirmed.
To our knowledge, this is the first report that low dose cosyntropin stimulation test is a helpful diagnostic procedure for primary adrenal insufficiency. Further accumulated cases with Addison's disease need to be necessary in order to establish the test. However, there are not many patients with Addison's disease who have normal response to 250 µg cosyntropin [6, 7, 11, 12] . In addition, we think that it would be difficult to design the study and recruit the cases with a similar condition of primary adrenal insufficiency in contrast to secondary or relative adrenal insufficiency because the etiology varies so widely.
In conclusion, we present this case to emphasize the validity of 1 µg cosyntropin stimulation test in patients with primary adrenal insufficiency as well as in secondary or relative adrenal insufficiency. It is important to make an accurate diagnosis of Addison's disease because of the life-threatening nature of the disorder. Patients who are suspected of having Addison's disease, even with a normal cortisol response to 250 µg of cosyntropin, should be examined using the 1 µg cosyntropin stimulation test to confirm the diagnosis.
